Palliative Care of Pancreatic Cancer
Abstract
Pancreatic cancer is one of the most fatal malignancies. Palliative care represents an important aspect of management in patients with pancreatic malignancy. Identifying and treating disease related symptoms are very important. As a physician taking care of these patients it is essential to know these symptoms and treatment modalities. Common problems include biliary obstruction, anticoagulation, and pain management. This review discusses the data presented at the 2011 American Society of Clinical Oncology (ASCO) Annual Meeting symptom management and supportive care strategies including Abstracts #e14665, #e14622, and #LBA9014. Success is needed in managing these symptoms to palliate patients with advanced pancreatic cancer. It is important for oncologists to recognize the importance of supportive measures that can minimize the symptoms of advanced disease and side effects of cancer treatment.
Image: The Thinker (Le Penseur) of Auguste Rodin at Columbia University, New York, NY, USA
Downloads
References
Fazal S, Saif MW. Supportive and palliative care of pancreatic cancer. JOP. J Pancreas (Online) 2007; 8:240-53.
Espinoza AM, Ko AH, Ostroff JW, Venook AP, Bergsland EK, Kelley RK, et al. Biliary stent complications in clinical trials for advanced pancreatic cancer. J Clin Oncol 2011; 29(Suppl.):e14665.
Kar SP, Bhosale P, Overman MJ, Weatherly J, Xiao L, Wolff RA, Javle MM. Role of anticoagulation (AC) in patients with advanced pancreatic cancer (APC) with splanchnic venous thrombosis (SVT). J Clin Oncol 2011; 29(Suppl.):e14622.
Sohail MA, Saif MW. Role of anticoagulation in the management of pancreatic cancer. JOP. J Pancreas (Online) 2009; 10:82-7.
Agnelli G, George DJ, Fisher W, Kakkar AK, Lassen MR, Mismetti P, et al. The ultra-low molecular weight heparin (ULMWH) semuloparin for prevention of venous thromboembolism (VTE) in patients with cancer receiving chemotherapy: SAVE ONCO study. J Clin Oncol 2011; 29(Suppl.):LBA9014.
Copyright (c) 2011 Muhammad Wasif Saif
This work is licensed under a Creative Commons Attribution 4.0 International License.
As a member of Publisher International Linking Association, PILA, iMedPub Group’s JOP follows the Creative Commons Attribution License and Scholars Open Access publishing policies. Journal of the Pancreas is the Council Contributor Member of Council of Science Editors (CSE) and following the CSE slogan Education, Ethics, and Evidence for Editors.